LUMIGAN: payments to doctors
Payments that named LUMIGAN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.5M
- Providers
- 18,612
- Transactions
- 116,024
- Average per transaction
- $48
The per-transaction average — $48 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 18,612 providers the average total is $297, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AbbVie | $5,523,148 | 100.0% |